PCI in Post Thrombolysis Stable STEMI Patients: A Timeline in Question


ST elevation myocardial infarction (STEMI) occupies a significant portion of the cardiovascular disease spectrum and poses a continuing challenge on the health care delivery system worldwide. A dilemma exists in the clinical triage system for appropriate strategic modalities of treatment, based on underlying triad of patient-hospital-cardiac pathological factors as well as cut off timelines. Current European Society of Cardiology (ESC) guideline recommends percutaneous coronary intervention (PCI) within 3 to 24 hours in post thrombolysis stable patients. This review critically evaluated the evidences underlying the ESC recommendation. Trials included in this review are SIAM III, GRACIA 1, CAPITAL-AMI, CARESS-IN-AMI, NORDISTEMI, PRAGUE-1, WEST and LEIPZIG. Most of the evidences support the notion for immediate post thrombolysis PCI in stable patients within 1.9 to 2.7 hours, which contradicts the ESC timeline of up to 24 hours. Also, there is a reduced generalizability of the trial results due to differences in the design of the various trials, study population, composite endpoints, variations in drug dose & formulation, co-administration of pharmacotherapies and type of stents used. This warrants further research for standardization & optimization of the treatment protocol with respect to post thrombolysis PCI in stable STEMI patients.

Share and Cite:

Hasan, I. , Rashid, T. and Bhuiyan, M. (2015) PCI in Post Thrombolysis Stable STEMI Patients: A Timeline in Question. World Journal of Cardiovascular Diseases, 5, 335-342. doi: 10.4236/wjcd.2015.512039.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Kumar, A. and Cannon, C.P. (2009) Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clinic Proceedings, 84, No. 10.
[2] Yun, D. and Alpert, J. (1997) Acute Coronary Syndromes. Cardiology, 88, 223-237.
[3] Go, A.S., et al. (2013) AHA Statistical Update. Circulation, 129, e28-e292.
[4] Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States a Policy Statement from the American Heart Association. Circulation, 123, 933-944.
[5] Turpie, A.G. (2006) Burden of Disease: Medical and Economic Impact of Acute Coronary Syndromes. American Journal of Managed Care, 12, S430.
[6] O’Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. (2013) 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61, e78-e140.
[7] AHA (2015) STEMI Systems of Care.
[8] Steg, P.G., et al. (2012) ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. European Heart Journal, 33, 2569-2619.
[9] Rogers, W.J., Canto, J.G., Lambrew, C.T., et al. (2000) Temporal Trends in the Treatment of over 1.5 Million Patients with Myocardial Infarction in the US from 1990 through 1999: The Na-tional Registry of Myocardial Infarction 1, 2 and 3. Journal of the American College of Cardiology, 36, 2056-2063.
[10] Windecker, S., et al. (2014) 2014 ESC/EACTS Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the Special Contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal, 2014, ehu278.
[11] Kleinschmidt, K.C. (2006) Epidemiology and Pathophysiology of Acute Coronary Syndrome. John Hopkins Advanced Studies in Nursing, 4, 72-77.
[12] Nakamura, M. (2010) Angiography Is the Gold Standard and Objective Evidence of Myocardial Ischemia Is Mandatory If Lesion Severity Is Questionable. Indication of PCI for Angiographically Significant Coronary Artery Stenosis without Objective Evidence of Myocardial Ischemia (Pro). Circulation Journal: Official Journal of the Japanese Circulation Society, 75, 204-217.
[13] Bonnefoy, E., Lapostolle, F., Leizorovicz, A., Steg, G., McFadden, E.P., Dubien, P.Y., et al. (2002) Primary Angioplasty versus Prehospital Fibrinolysis in Acute Myocardial Infarction: A Randomised Study. The Lancet, 360, 825-829.
[14] Bonnefoy, E., Steg, P.G., Boutitie, F., Dubien, P.Y., Lapostolle, F., Roncalli, J., et al. (2009) Comparison of Primary Angioplasty and Pre-Hospital Fibrinolysis in Acute Myocardial Infarction (CAPTIM) Trial: A 5-Year Follow-Up. European Heart Journal, 30, 1598-1606.
[15] Armstrong, P.W., Gershlick, A.H., Goldstein, P., Wilcox, R., Danays, T., Lambert, Y., et al. (2013) Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction. New England Journal of Medicine, 368, 1379-1387.
[16] Appleby, P., et al. (1994) Indications for Fibrinolytic Therapy in Suspected Acute Myocardial Infarction: Collaborative Overview of Early Mortality and Major Morbidity Results from All Randomised Trials of More Than. The Lancet, 343, 311-322.
[17] Gershlick, A.H., Banning, A.P., Myat, A., Verheugt, F.W.A. and Gersh, B.J. (2013) Reperfusion Therapy for STEMI: Is There Still a Role for Thrombolysis in the Era of Primary Percutaneous Coronary Intervention? The Lancet, 382, 624-632.
[18] Miedema, M.D., Newell, M.C., Duval, S., Garberich, R.F., Handran, C.B., Larson, D.M., et al. (2011) Causes of Delay and Associated Mortality in Patients Transferred with ST-Segment-Elevation Myocardial Infarction. Circulation, 124, 1636-1644.
[19] Herrin, J., Miller, L.E., Turkmani, D.F., Nsa, W., Drye, E.E., Bernheim, S.M., et al. (2011) National Performance on Door-In to Door-Out Time among Patients Transferred for Primary Percutaneous Coronary Intervention. Archives of Internal Medicine, 171, 1879-1886.
[20] Scheller, B., Hennen, B., Hammer, B., Walle, J., Hofer, C., Hilpert, V., et al. (2003) Beneficial Effects of Immediate Stenting after Thrombolysis in Acute Myocardial Infarction. Journal of the American College of Cardiology, 42, 634-641.
[21] Fernandez-Avilés, F., Alonso, J.J., Castro-Beiras, A., Vázquez, N., Blanco, J., Alonso-Briales, J., et al. (2004) Routine Invasive Strategy within 24 Hours of Thrombolysis versus Ischaemia-Guided Conservative Approach for Acute Myocardial Infarction with ST-Segment Elevation (GRACIA-1): A Randomised Controlled Trial. The Lancet, 364, 1045- 1053.
[22] Le May, M.R., Wells, G.A., Labinaz, M., Davies, R.F., Turek, M., Leddy, D., et al. (2005) Combined Angioplasty and Pharmacological Intervention versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study). Journal of the American College of Cardiology, 46, 417-424.
[23] Di Mario, C., Dudek, D., Piscione, F., Mielecki, W., Savonitto, S., Murena, E., et al. (2008) Immediate Angioplasty versus Standard Therapy with Rescue Angioplasty after Thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): An Open, Prospective, Randomised, Multicentre Trial. The Lancet, 371, 559-568.
[24] Cantor, W.J., Fitchett, D., Borgundvaag, B., Ducas, J., Heffernan, M., Cohen, E.A., et al. (2009) Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. New England Journal of Medicine, 360, 2705-2718.
[25] B?hmer, E., Hoffmann, P., Abdelnoor, M., Arnesen, H. and Halvorsen, S. (2010) Efficacy and Safety of Immediate Angioplasty versus Ischemia-Guided Management after Thrombolysis in Acute Myocardial Infarction in Areas with Very Long Transfer Distances: Results of the NORDISTEMI (Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction). Journal of the American College of Cardiology, 55, 102-110.
[26] Collet, J.-P., Montalescot, G., May, M.L., Borentain, M. and Gershlick, A. (2006) Percutaneous Coronary Intervention after Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy. Journal of the American College of Cardiology, 48, 1326-1335.
[27] Desch, S., Eitel, I., Rahimi, K., de Waha, S., Schuler, G. and Thiele, H. (2010) Timing of Invasive Treatment after Fibrinolysis in ST Elevation Myocardial Infarction—A Me-ta-Analysis of Immediate or Early Routine versus Deferred or Ischemia-Guided Randomised Controlled Trials. Heart, 96, 1695-1702.
[28] Borgia, F., Goodman, S.G., Halvorsen, S., Cantor, W.J., Piscione, F., May, M.L., et al. (2010) Early Routine Percutaneous Coronary Intervention after Fibrinolysis vs. Standard Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-Analysis. European Heart Journal, 31, 2156-2169.
[29] D'Souza, S.P., Mamas, M.A., Fraser, D.G. and Fath-Ordoubadi, F. (2011) Routine Early Coronary Angioplasty versus Ischaemia-Guided Angioplasty after Thrombolysis in Acute ST-Elevation Myocardial Infarction: A Meta-Analysis. European Heart Journal, 32, 972-982.
[30] Hochman, J.S., Lamas, G.A., Buller, C.E., Dzavik, V., Reynolds, H.R., Abramsky, S.J., et al. (2006) Coronary Intervention for Persistent Occlusion after Myocardial Infarction. New England Journal of Medicine, 355, 2395-2407.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.